retatrutide phase 2 study results This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Trial https://t.co/jNL1GNnHPT #Endocrinology ESC 2024: Retatrutide improves lipid

[2] mhra.gov.uk)

I have lost 25 pounds so far! Mike S

Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss

On average, breastfeeding mothers need about 2,000 calories per day plus an additional ~250 calories for milk production sometimes more depending on body size and milk output

The cost of treatment varies by medication and insurance coverage and is billed separately from your membership

Diabetes 45 , 832835 (1996)